Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain
- PMID: 21084778
- DOI: 10.3810/pgm.2010.11.2219
Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain
Abstract
Cotrimoxazole, an association of trimethoprim and sulfamethoxazole, and dapsone, are mainstays for the prophylaxis and treatment of Pneumocystis pneumonia (PcP). The inability to culture Pneumocystis prevents routine susceptibility testing and detection of drug resistance. Instead, molecular techniques have been used to detect Pneumocystis jiroveci dihydropteroate synthase (DHPS) mutations that cause sulfa resistance in other microorganisms. The most frequent DHPS mutations occur at nucleotide positions 165 and 171, which lead to an amino acid change at positions 55 and 57. Several studies suggest that these mutations are associated with the failure of chemoprophylaxis for PcP. The aim was to establish the frequency and characteristics of P jiroveci DHPS mutations among colonized individuals and PcP patients from Spain. A total of 50 colonized individuals and 25 PcP patients were studied. DHPS polymorphisms were identified by restriction fragment length polymorphism assay. The analysis provided a rate of 28% of DHPS gene mutations in our population, with the presence of all possible polymorphisms described. The presence of mutations was higher in PcP patients than in colonized subjects (40% vs 22%), probably because of the chemoprophylaxis used in PcP patients. The comparison between patients with and without DHPS mutations did not show statistical differences due to age, sex, steroid use, sulfa drug exposure, or smoking. A high rate of DHPS mutations in our area of Spain, not only confined to patients previously exposed to sulfa drugs, is shown in this study. As well as PcP patients, colonized individuals who harbor P jiroveci strains with DHPS mutations could play a major role in the transmission cycle of these mutations, representing a reservoir and source of infection for susceptible individuals. Further research is thus warranted to assess the true scope of the problem and to design rational preventive strategies.
Similar articles
-
High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01290-16. doi: 10.1128/AAC.01290-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27855071 Free PMC article.
-
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.Emerg Infect Dis. 2004 Oct;10(10):1721-8. doi: 10.3201/eid1010.030994. Emerg Infect Dis. 2004. PMID: 15504256 Free PMC article. Review.
-
Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations.Clin Infect Dis. 2010 Aug 15;51(4):e28-33. doi: 10.1086/655145. Clin Infect Dis. 2010. PMID: 20604718
-
Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae.Clin Microbiol Infect. 2010 May;16(5):501-7. doi: 10.1111/j.1469-0691.2009.02833.x. Epub 2009 Aug 10. Clin Microbiol Infect. 2010. PMID: 19673964
-
[Human reservoirs of Pneumocystis].Enferm Infecc Microbiol Clin. 2010 Jan;28(1):38-43. doi: 10.1016/j.eimc.2008.07.008. Epub 2009 Apr 29. Enferm Infecc Microbiol Clin. 2010. PMID: 19403207 Review. Spanish.
Cited by
-
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.J Antimicrob Chemother. 2022 Jul 28;77(8):2053-2073. doi: 10.1093/jac/dkac161. J Antimicrob Chemother. 2022. PMID: 35703391 Free PMC article. Review.
-
Pneumocystis jirovecii infection and the associated dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) mutations in HIV-positive individuals from Pune, India.Mycopathologia. 2015 Feb;179(1-2):141-5. doi: 10.1007/s11046-014-9818-5. Epub 2014 Sep 30. Mycopathologia. 2015. PMID: 25266324
-
Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.PLoS One. 2020 Sep 10;15(9):e0238184. doi: 10.1371/journal.pone.0238184. eCollection 2020. PLoS One. 2020. PMID: 32911508 Free PMC article.
-
Update on Dihydropteroate Synthase (DHPS) Mutations in Pneumocystis jirovecii.J Fungi (Basel). 2021 Oct 13;7(10):856. doi: 10.3390/jof7100856. J Fungi (Basel). 2021. PMID: 34682277 Free PMC article. Review.
-
A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.Clin Microbiol Rev. 2018 Jun 13;31(3):e00009-18. doi: 10.1128/CMR.00009-18. Print 2018 Jul. Clin Microbiol Rev. 2018. PMID: 29899010 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials